↓ Skip to main content

Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer

Overview of attention for article published in Clinical and Translational Medicine, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 689)
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
5 tweeters
facebook
1 Facebook page
wikipedia
5 Wikipedia pages
video
1 video uploader

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
173 Mendeley
citeulike
1 CiteULike
Title
Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
Published in
Clinical and Translational Medicine, November 2012
DOI 10.1186/2001-1326-1-29
Pubmed ID
Authors

Belinda Seto

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
India 1 <1%
Unknown 170 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 44 25%
Student > Bachelor 32 18%
Student > Master 23 13%
Researcher 15 9%
Student > Doctoral Student 12 7%
Other 22 13%
Unknown 25 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 49 28%
Biochemistry, Genetics and Molecular Biology 40 23%
Medicine and Dentistry 19 11%
Pharmacology, Toxicology and Pharmaceutical Science 12 7%
Chemistry 10 6%
Other 15 9%
Unknown 28 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2022.
All research outputs
#1,188,027
of 21,514,875 outputs
Outputs from Clinical and Translational Medicine
#34
of 689 outputs
Outputs of similar age
#21,964
of 302,411 outputs
Outputs of similar age from Clinical and Translational Medicine
#2
of 26 outputs
Altmetric has tracked 21,514,875 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 689 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 302,411 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.